These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32711119)
21. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma. Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319 [TBL] [Abstract][Full Text] [Related]
22. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression. Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041 [TBL] [Abstract][Full Text] [Related]
23. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125 [TBL] [Abstract][Full Text] [Related]
24. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma. Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells. Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400 [TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086 [TBL] [Abstract][Full Text] [Related]
29. MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma. Xue Z; Wu X; Chen X; Luo Q Cancer Med; 2016 Sep; 5(9):2459-68. PubMed ID: 27292876 [TBL] [Abstract][Full Text] [Related]
30. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409 [TBL] [Abstract][Full Text] [Related]
31. EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma. Ardalan Khales S; Forghanifard MM; Abbaszadegan MR; Hosseini SE Adv Med Sci; 2023 Mar; 68(1):21-30. PubMed ID: 36403545 [TBL] [Abstract][Full Text] [Related]
32. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2. Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099 [TBL] [Abstract][Full Text] [Related]
33. [Serum level of lncRNA TUSC7 in patients with esophageal squamous cell carcinoma and its role in promoting tumor cell migration and invasion]. Zhao K; Guo Y; Huo Z; Ma G; Zhang G; Xing Y; Xu Q Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):661-669. PubMed ID: 32897196 [TBL] [Abstract][Full Text] [Related]
34. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239 [TBL] [Abstract][Full Text] [Related]
35. Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer. Lee KW; Lee NK; Kim JH; Kang MS; Yoo HY; Kim HH; Um SH; Kim SH Biochem Biophys Res Commun; 2012 Jul; 423(3):454-60. PubMed ID: 22668877 [TBL] [Abstract][Full Text] [Related]
36. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses. Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665 [TBL] [Abstract][Full Text] [Related]
38. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway. Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260 [TBL] [Abstract][Full Text] [Related]
39. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma. Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500 [TBL] [Abstract][Full Text] [Related]
40. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo. Liang F; Wang YG; Wang C Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]